Technology insight: Identification of biomarkers with tissue microarray technology (Q36303882)

13 August 2017

1 reference

title

Technology insight: Identification of biomarkers with tissue microarray technology (English)

1 reference

13 August 2017

0 references

Jena M Giltnane

1

1 reference

PubMed ID

16264828

13 August 2017

David L Rimm

series ordinal

2

1 reference

13 August 2017

1 December 2004

1 reference

Nature Clinical Practice Oncology

13 August 2017

1 reference

13 August 2017

1

1 reference

13 August 2017

2

1 reference

13 August 2017

104-111

1 reference

https://scigraph.springernature.com/pub.10.1038/ncponc0046

13 August 2017

0 references

cites work

A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Molecular portraits and the family tree of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Tissue microarray sampling strategy for prostate cancer biomarker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Tissue microarrays in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Automated subcellular localization and quantification of protein expression in tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Medicine. The NIH Roadmap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Full speed ahead for tumor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

Applications of microarrays to histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

RFID. A key to automating everything

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Validation of tissue microarray technology in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Assessment of HER-2/neu Status in Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Tissue microarray (TMA) applications: implications for molecular medicine.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Tissue microarrays in cancer diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Issues and barriers to development of clinically useful tumor markers: a development pathway proposal

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0046

7 January 2021

Identifiers

DOI

10.1038/NCPONC0046

1 reference

PubMed ID

16264828

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16264828